Search for: "Astrazeneca"
Results 781 - 800
of 1,246
Sort by Relevance
|
Sort by Date
3 Nov 2010, 5:56 am
Astrazeneca Pharmaceuticals LP, et. al., 2-08-cv-04786 (PAED October 20, 2010, Memorandum and/or Opinion) (Yohn, J.) [read post]
3 Nov 2010, 1:21 am
No – discussion of patent-eligibility standards for genes (Patent Baristas) US: Appellees file reply brief in Therasense v Becton Dickinson (Patent Docs) US: Another Capitol Hill missive objects to the inclusion of patent settlement provisions in FY 2011 Appropriations Bill (FDA Law Blog) US: REMS and 180-day exclusivity forfeiture – some interesting disclosures to the SEC (FDA Law Blog) Products Botox (Botulinum) – EU: General Court upholds opposition to BOTUMAX Community… [read post]
2 Nov 2010, 9:23 pm
AstraZeneca v. [read post]
2 Nov 2010, 1:40 am
AstraZeneca v. [read post]
29 Oct 2010, 4:32 pm
9/1/2010 - Off-label marketing practices involving Botox AstraZeneca - $520 M- 4/27/2010 - Illegal marketing - anti-psychotic drug Seroquel Novartis Pharmaceuticals $422.5 million ($237.5 M - Civil allegations and a $185 M criminal fine) 9/30/2010 Unapproved promotion of Trileptal Forest Laboratories - $313 M - ($149M -Civil claims, a $150M criminal fine, and $14 M… [read post]
27 Oct 2010, 12:17 pm
AstraZeneca was premised on the century-old axiom in patent law that "a product which would literally infringe if later in time anticipates if earlier. [read post]
27 Oct 2010, 8:57 am
Trailing just behind was AstraZeneca, which paid $520 million over allegations it inappropriately marketed its psychiatric drug Seroquel. [read post]
27 Oct 2010, 8:57 am
Trailing just behind was AstraZeneca, which paid $520 million over allegations it inappropriately marketed its psychiatric drug Seroquel. [read post]
24 Oct 2010, 10:10 pm
In addition to Lilly and Cephalon, the companies include AstraZeneca, GlaxoSmithKline, Johnson & Johnson, Merck & Co., and Pfizer. [read post]
19 Oct 2010, 9:09 am
Other pharmaceutical companies reviewed were Pfizer, AstraZeneca, GlaxoSmithKline, Merck & Co., Cephalon and the Johnson & Johnson companies. [read post]
19 Oct 2010, 8:06 am
AstraZeneca PLC, Senior District Judge J. [read post]
15 Oct 2010, 12:00 am
ABSTRACT: On July 1, 2010, the General Court issued its long awaited judgment in AstraZeneca v... [read post]
15 Oct 2010, 12:00 am
ABSTRACT: On July 1, 2010, the General Court issued its long awaited judgment in AstraZeneca v... [read post]
14 Oct 2010, 12:00 am
Daniel Sokol Kristina Nordlander & Patrick Harrison (Sidley Austin) predict the General Court’s AstraZeneca Judgment Set to Embolden Commission. [read post]
14 Oct 2010, 12:00 am
Daniel Sokol Kristina Nordlander & Patrick Harrison (Sidley Austin) predict the General Court’s AstraZeneca Judgment Set to Embolden Commission. [read post]
13 Oct 2010, 6:48 am
Created by AstraZeneca, raltitrexed is an antimetabolite, a chemical that stops the growth and division of cells. [read post]
12 Oct 2010, 8:56 pm
Apotex asks Supreme Court to review generic Cozaar/Hyzaar 180-day exclusivity decision (FDA Law Blog) Faslodex (Fulvestrant) – US: AstraZeneca seeks review of BPAI decision concerning patent covering ‘Use of Fulvestrant in treatment of resistant breast cancer’ (Patent Docs) Gemzar (Gemcitabine) – US: Eli Lilly files patent infringement complaint against Dr Reddy’s following Para IV certification (Patent Docs) Lipitor (Atorvastatin) – US: Generic LIPITOR… [read post]
12 Oct 2010, 12:00 am
Daniel Sokol David Hull (Covington) explains The AstraZeneca Judgment: Implications for IP and Regulatory Strategies. [read post]
12 Oct 2010, 12:00 am
Daniel Sokol David Hull (Covington) explains The AstraZeneca Judgment: Implications for IP and Regulatory Strategies. [read post]
6 Oct 2010, 7:46 am
AstraZeneca LP, 372 F. [read post]
